Correlation Between Pharmaceuticals Ultrasector and Biotechnology Ultrasector

Can any of the company-specific risk be diversified away by investing in both Pharmaceuticals Ultrasector and Biotechnology Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmaceuticals Ultrasector and Biotechnology Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharmaceuticals Ultrasector Profund and Biotechnology Ultrasector Profund, you can compare the effects of market volatilities on Pharmaceuticals Ultrasector and Biotechnology Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmaceuticals Ultrasector with a short position of Biotechnology Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmaceuticals Ultrasector and Biotechnology Ultrasector.

Diversification Opportunities for Pharmaceuticals Ultrasector and Biotechnology Ultrasector

0.81

Correlation Coefficient

Pharmaceuticals Ultrasector  Biotechnology Ultrasector

Very poor diversification

The 3 months correlation between Pharmaceuticals and Biotechnology is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Pharmaceuticals Ultrasector Pr and Biotechnology Ultrasector Prof in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Ultrasector and Pharmaceuticals Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmaceuticals Ultrasector Profund are associated (or correlated) with Biotechnology Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Ultrasector has no effect on the direction of Pharmaceuticals Ultrasector i.e., Pharmaceuticals Ultrasector and Biotechnology Ultrasector go up and down completely randomly.

Pair Corralation between Pharmaceuticals Ultrasector and Biotechnology Ultrasector

Assuming the 90 days horizon Pharmaceuticals Ultrasector Profund is expected to generate 0.8 times more return on investment than Biotechnology Ultrasector. However, Pharmaceuticals Ultrasector Profund is 1.25 times less risky than Biotechnology Ultrasector. It trades about -0.09 of its potential returns per unit of risk. Biotechnology Ultrasector Profund is currently generating about -0.1 per unit of risk. If you would invest  2,615  in Pharmaceuticals Ultrasector Profund on February 11, 2025 and sell it today you would lose (442.00) from holding Pharmaceuticals Ultrasector Profund or give up 16.9% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Pharmaceuticals Ultrasector Pr  vs.  Biotechnology Ultrasector Prof

Pharmaceuticals Ultrasector

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pharmaceuticals Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's forward indicators remain fairly strong which may send shares a bit higher in June 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Biotechnology Ultrasector

Risk-Adjusted Performance

Very Weak

Over the last 90 days Biotechnology Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's forward indicators remain fairly strong which may send shares a bit higher in June 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Pair Trading with Pharmaceuticals Ultrasector and Biotechnology Ultrasector

The main advantage of trading using opposite Pharmaceuticals Ultrasector and Biotechnology Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmaceuticals Ultrasector position performs unexpectedly, Biotechnology Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Ultrasector will offset losses from the drop in Biotechnology Ultrasector's long position.

The idea behind Pharmaceuticals Ultrasector Profund and Biotechnology Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.